Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Alpine Immune Sciences, Inc. (NVLS) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Alpine Immune Sciences, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1626199.
Total stock buying since 2015: $68,364,405.
Total stock sales since 2015: $99,301,024.
Total stock option exercises since 2015: $5,550,500.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 0 | $0 | 118,019 | $2,792,243 | 601,428 | $4,284,669 |
| 2023 | 0 | $0 | 3,469,510 | $66,117,796 | 334,856 | $1,197,800 |
| 2022 | 112,665 | $800,034 | 0 | $0 | 20,063 | $9,028 |
| 2021 | 5,116,380 | $48,097,940 | 1,352,414 | $13,055,502 | 15,300 | $59,003 |
| 2020 | 10,000 | $80,300 | 1,200,000 | $17,100,000 | 0 | $0 |
| 2019 | 2,072,381 | $11,124,482 | 25,000 | $146,250 | 0 | $0 |
| 2017 | 385,348 | $885,352 | 6,687 | $15,179 | 18,055 | $0 |
| 2016 | 10,000 | $40,430 | 11,770 | $74,054 | 36,111 | $0 |
| 2015 | 528,749 | $7,335,867 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-05 | 0 | $0 | 0 | $0 | 483,428 | $3,233,856 |
| 2024-04 | 0 | $0 | 19 | $1,226 | 0 | $0 |
| 2024-01 | 0 | $0 | 118,000 | $2,791,017 | 118,000 | $1,050,813 |
| 2023-12 | 0 | $0 | 3,450,807 | $65,818,044 | 323,167 | $1,160,045 |
| 2023-11 | 0 | $0 | 18,703 | $299,752 | 11,689 | $37,755 |
| 2022-07 | 0 | $0 | 0 | $0 | 20,063 | $9,028 |
| 2022-02 | 112,665 | $800,034 | 0 | $0 | 0 | $0 |
| 2021-09 | 5,116,380 | $48,097,940 | 1,272,414 | $12,113,833 | 0 | $0 |
| 2021-05 | 0 | $0 | 20,000 | $232,010 | 0 | $0 |
| 2021-04 | 0 | $0 | 20,000 | $205,910 | 0 | $0 |
| 2021-03 | 0 | $0 | 20,000 | $259,989 | 15,300 | $59,003 |
| 2021-02 | 0 | $0 | 20,000 | $243,760 | 0 | $0 |
| 2020-12 | 0 | $0 | 1,200,000 | $17,100,000 | 0 | $0 |
| 2020-11 | 10,000 | $80,300 | 0 | $0 | 0 | $0 |
| 2019-05 | 10,000 | $49,500 | 0 | $0 | 0 | $0 |
| 2019-02 | 0 | $0 | 25,000 | $146,250 | 0 | $0 |
| 2019-01 | 2,062,381 | $11,074,982 | 0 | $0 | 0 | $0 |
| 2017-06 | 90,456 | $206,134 | 0 | $0 | 0 | $0 |
| 2017-05 | 294,892 | $679,218 | 0 | $0 | 0 | $0 |
| 2017-01 | 0 | $0 | 6,687 | $15,179 | 18,055 | $0 |
| 2016-10 | 0 | $0 | 5,820 | $46,327 | 18,056 | $0 |
| 2016-07 | 0 | $0 | 5,950 | $27,727 | 18,055 | $0 |
| 2016-06 | 5,000 | $19,345 | 0 | $0 | 0 | $0 |
| 2016-03 | 5,000 | $21,085 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-05-08 | Fuhs Ulrich Martin (Chief Accounting Officer) | Option Ex | 22,820 | 12.07 | 275,437 |
| 2024-05-08 | Durand Remy (Chief Business Officer) | Option Ex | 95,288 | 6.36 | 605,841 |
| 2024-05-08 | Peng Stanford L (See Remarks) | Option Ex | 271,792 | 5.98 | 1,626,131 |
| 2024-05-08 | Gold Mitchell (Executive Chairman and CEO) | Option Ex | 13,245 | 7.55 | 99,999 |
| 2024-05-07 | Rickey James Paul (See Remarks) | Option Ex | 53,522 | 7.80 | 417,632 |
| 2024-04-25 | Topper James N | Sale | 19 | 64.57 | 1,226 |
| 2024-01-26 | Rickey James Paul (See Remarks) | Sale | 117,764 | 23.66 | 2,785,825 |
| 2024-01-26 | Rickey James Paul (See Remarks) | Option Ex | 117,764 | 8.91 | 1,049,277 |
| 2024-01-25 | Rickey James Paul (See Remarks) | Sale | 236 | 22.00 | 5,192 |
| 2024-01-25 | Rickey James Paul (See Remarks) | Option Ex | 236 | 6.51 | 1,536 |
| 2023-12-28 | Orbimed Genesis Gp Llc | Sale | 1,364,849 | 19.07 | 26,027,670 |
| 2023-12-28 | Thompson Peter A. | Sale | 1,364,849 | 19.07 | 26,027,670 |
| 2023-12-28 | Gold Mitchell (Executive Chairman and CEO) | Sale | 1,016 | 20.04 | 20,361 |
| 2023-12-28 | Gold Mitchell (Executive Chairman and CEO) | Option Ex | 75,457 | 6.70 | 505,184 |
| 2023-12-27 | Orbimed Genesis Gp Llc | Sale | 181,498 | 19.96 | 3,622,700 |
| 2023-12-27 | Thompson Peter A. | Sale | 181,498 | 19.96 | 3,622,700 |
| 2023-12-27 | Gold Mitchell (Executive Chairman and CEO) | Sale | 29,573 | 20.04 | 592,731 |
| 2023-12-27 | Gold Mitchell (Executive Chairman and CEO) | Option Ex | 29,573 | .65 | 19,222 |
| 2023-12-26 | Gold Mitchell (Executive Chairman and CEO) | Sale | 24,486 | 20.23 | 495,229 |
| 2023-12-26 | Gold Mitchell (Executive Chairman and CEO) | Option Ex | 24,486 | .55 | 13,467 |
| 2023-12-22 | Gold Mitchell (Executive Chairman and CEO) | Sale | 37,825 | 20.43 | 772,613 |
| 2023-12-22 | Gold Mitchell (Executive Chairman and CEO) | Option Ex | 37,825 | .45 | 17,021 |
| 2023-12-19 | Rickey James Paul (See Remarks) | Sale | 15,213 | 19.21 | 292,226 |
| 2023-12-19 | Rickey James Paul (See Remarks) | Option Ex | 15,213 | 5.02 | 76,369 |
| 2023-12-19 | Gold Mitchell (Executive Chairman and CEO) | Sale | 2,402 | 20.01 | 48,064 |
| 2023-12-19 | Gold Mitchell (Executive Chairman and CEO) | Option Ex | 2,402 | .45 | 1,080 |
| 2023-12-18 | Rickey James Paul (See Remarks) | Sale | 1,800 | 19.00 | 34,203 |
| 2023-12-18 | Rickey James Paul (See Remarks) | Option Ex | 1,800 | 5.02 | 9,036 |
| 2023-12-15 | Rickey James Paul (See Remarks) | Sale | 45,387 | 19.09 | 866,392 |
| 2023-12-15 | Rickey James Paul (See Remarks) | Option Ex | 45,387 | 5.02 | 227,842 |
| 2023-12-14 | Rickey James Paul (See Remarks) | Sale | 11,600 | 19.00 | 220,411 |
| 2023-12-14 | Rickey James Paul (See Remarks) | Option Ex | 11,600 | 5.02 | 58,231 |
| 2023-12-12 | Gold Mitchell (Executive Chairman and CEO) | Sale | 41,063 | 17.32 | 711,046 |
| 2023-12-12 | Gold Mitchell (Executive Chairman and CEO) | Option Ex | 8,613 | .45 | 3,875 |
| 2023-12-11 | Gold Mitchell (Executive Chairman and CEO) | Sale | 68,870 | 17.27 | 1,189,040 |
| 2023-12-08 | Gold Mitchell (Executive Chairman and CEO) | Sale | 8,067 | 17.08 | 137,784 |
| 2023-12-06 | Rickey James Paul (See Remarks) | Sale | 6,446 | 16.08 | 103,651 |
| 2023-12-06 | Rickey James Paul (See Remarks) | Option Ex | 6,446 | 3.23 | 20,820 |
| 2023-12-05 | Rickey James Paul (See Remarks) | Sale | 418 | 16.01 | 6,693 |
| 2023-12-05 | Rickey James Paul (See Remarks) | Option Ex | 418 | 3.23 | 1,350 |
| 2023-12-04 | Rickey James Paul (See Remarks) | Sale | 63,947 | 16.06 | 1,026,860 |
| 2023-12-04 | Rickey James Paul (See Remarks) | Option Ex | 63,947 | 3.23 | 206,548 |
| 2023-11-30 | Rickey James Paul (See Remarks) | Sale | 700 | 16.00 | 11,200 |
| 2023-11-30 | Rickey James Paul (See Remarks) | Option Ex | 700 | 3.23 | 2,261 |
| 2023-11-06 | Rickey James Paul (See Remarks) | Sale | 18,003 | 16.03 | 288,552 |
| 2023-11-06 | Rickey James Paul (See Remarks) | Option Ex | 10,989 | 3.23 | 35,494 |
| 2022-07-15 | Venkatesan Jay | Option Ex | 20,063 | .45 | 9,028 |
| 2022-02-11 | Topper James N (Director) | Buy | 112,665 | 7.10 | 800,034 |
| 2021-09-23 | Peetz Christopher | Sale | 1,900 | 10.17 | 19,323 |
| 2021-09-23 | Conway Robert E | Sale | 15,000 | 10.08 | 151,155 |
| 2021-09-21 | Conway Robert E | Buy | 10,000 | 9.80 | 97,970 |
| 2021-09-17 | Orbimed Genesis Gp Llc | Buy | 1,010,637 | 9.40 | 9,499,987 |
| 2021-09-17 | Decheng Capital Management Iii (cayman), Llc | Buy | 1,542,553 | 9.40 | 14,499,998 |
| 2021-09-17 | Alpine Bioventures, Gp, Llc | Sale | 400,000 | 9.40 | 3,760,000 |
| 2021-09-17 | Cui Xiangmin | Buy | 1,542,553 | 9.40 | 14,499,998 |
| 2021-09-17 | Venkatesan Jay | Sale | 400,000 | 9.40 | 3,760,000 |
| 2021-09-17 | Thompson Peter A. | Buy | 1,010,637 | 9.40 | 9,499,987 |
| 2021-09-17 | Gold Mitchell (Executive Chairman and CEO) | Sale | 445,262 | 9.70 | 4,320,822 |
| 2021-09-16 | Gold Mitchell (Executive Chairman and CEO) | Sale | 6,768 | 10.00 | 67,693 |
| 2021-09-15 | Gold Mitchell (Executive Chairman and CEO) | Sale | 3,484 | 10.00 | 34,840 |
| 2021-05-13 | Gold Mitchell (Executive Chairman and CEO) | Sale | 10,000 | 11.52 | 115,170 |
| 2021-05-12 | Gold Mitchell (Executive Chairman and CEO) | Sale | 10,000 | 11.68 | 116,840 |
| 2021-04-14 | Gold Mitchell (Executive Chairman and CEO) | Sale | 10,000 | 10.52 | 105,200 |
| 2021-04-13 | Gold Mitchell (Executive Chairman and CEO) | Sale | 10,000 | 10.07 | 100,710 |
| 2021-03-31 | Venkatesan Jay | Option Ex | 7,650 | 3.62 | 27,715 |
| 2021-03-30 | Venkatesan Jay | Option Ex | 7,650 | 4.09 | 31,288 |
| 2021-03-05 | Gold Mitchell (Executive Chairman and CEO) | Sale | 10,000 | 12.99 | 129,880 |
| 2021-03-04 | Gold Mitchell (Executive Chairman and CEO) | Sale | 10,000 | 13.01 | 130,109 |
| 2021-02-02 | Gold Mitchell (Executive Chairman and CEO) | Sale | 10,000 | 11.74 | 117,380 |
| 2021-02-01 | Gold Mitchell (Executive Chairman and CEO) | Sale | 10,000 | 12.64 | 126,380 |
| 2020-12-28 | Orbimed Capital Gp Vi Llc | Sale | 600,000 | 14.25 | 8,550,000 |
| 2020-12-28 | Thompson Peter A. | Sale | 600,000 | 14.25 | 8,550,000 |
| 2020-11-19 | Conway Robert E (Director) | Buy | 10,000 | 8.03 | 80,300 |
| 2019-05-30 | Rickey James Paul (Senior VP and CFO) | Buy | 10,000 | 4.95 | 49,500 |
| 2019-02-08 | Tiger Management L.l.c. | Sale | 25,000 | 5.85 | 146,250 |
| 2019-01-18 | Alpine Bioventures, Gp, Llc (10% Owner) | Buy | 190,875 | 5.37 | 1,024,998 |
| 2019-01-18 | Orbimed Capital Gp Vi Llc | Buy | 372,439 | 5.37 | 1,999,997 |
| 2019-01-18 | Venkatesan Jay (Director) | Buy | 190,875 | 5.37 | 1,024,998 |
| 2019-01-18 | Heron Patrick J (10% Owner) | Buy | 372,439 | 5.37 | 1,999,997 |
| 2019-01-18 | Thompson Peter A. | Buy | 372,439 | 5.37 | 1,999,997 |
| 2019-01-18 | Topper James N (Director) | Buy | 372,439 | 5.37 | 1,999,997 |
| 2019-01-18 | Gold Mitchell (Executive Chairman and CEO) | Buy | 190,875 | 5.37 | 1,024,998 |
| 2017-06-20 | Lampert Mark N | Buy | 17,806 | 2.25 | 40,063 |
| 2017-06-07 | Lampert Mark N | Buy | 36,900 | 2.28 | 84,168 |
| 2017-06-05 | Lampert Mark N | Buy | 35,750 | 2.29 | 81,903 |
| 2017-05-31 | Lampert Mark N | Buy | 28,100 | 2.25 | 63,140 |
| 2017-05-30 | Lampert Mark N | Buy | 18,900 | 2.30 | 43,394 |
| 2017-05-19 | Lampert Mark N | Buy | 11,600 | 2.30 | 26,679 |
| 2017-05-18 | Lampert Mark N | Buy | 29,886 | 2.30 | 68,737 |
| 2017-05-17 | Lampert Mark N | Buy | 37,372 | 2.30 | 85,918 |
| 2017-05-11 | Lampert Mark N | Buy | 7,034 | 2.34 | 16,480 |
| 2017-05-10 | Lampert Mark N | Buy | 62,000 | 2.35 | 145,452 |
| 2017-05-09 | Lampert Mark N | Buy | 40,000 | 2.29 | 91,519 |
| 2017-05-09 | Conway Robert E (Director) | Buy | 5,000 | 2.34 | 11,700 |
| 2017-05-08 | Conway Robert E (Director) | Buy | 15,000 | 2.28 | 34,200 |
| 2017-05-05 | Conway Robert E (Director) | Buy | 20,000 | 2.30 | 46,000 |
| 2017-05-05 | Troha Janice (Exec Vice President / COO) | Buy | 10,000 | 2.34 | 23,400 |
| 2017-05-04 | Conway Robert E (Director) | Buy | 10,000 | 2.26 | 22,599 |
| 2017-01-04 | Rodman David Malcom (Exec Vice President and CMO) | Sale | 6,687 | 2.27 | 15,179 |
| 2017-01-03 | Rodman David Malcom (Exec Vice President and CMO) | Option Ex | 18,055 | .00 | 0 |
| 2016-10-04 | Rodman David Malcom (Exec Vice President and CMO) | Sale | 5,820 | 7.96 | 46,327 |
| 2016-10-03 | Rodman David Malcom (Exec Vice President and CMO) | Option Ex | 18,056 | .00 | 0 |
| 2016-07-05 | Rodman David Malcom (Exec Vice President and CMO) | Sale | 5,950 | 4.66 | 27,727 |
| 2016-07-01 | Rodman David Malcom (Exec Vice President and CMO) | Option Ex | 18,055 | .00 | 0 |
| 2016-06-16 | Congleton Jon (President and CEO) | Buy | 5,000 | 3.87 | 19,345 |
| 2016-03-24 | Congleton Jon (President and CEO) | Buy | 5,000 | 4.22 | 21,085 |
| 2015-12-11 | Congleton Jon (President and CEO) | Buy | 5,000 | 8.10 | 40,500 |
| 2015-12-09 | Conway Robert E (Director) | Buy | 10,000 | 8.10 | 81,000 |
| 2015-06-23 | Deerfield Private Design International Ii, L.p. | Buy | 250,000 | 14.00 | 3,500,000 |
| 2015-06-22 | Hawkes Bay Master Investors (cayman) L.p. (10% Owner) | Buy | 5,500 | 14.75 | 81,114 |
| 2015-06-22 | Rock Springs Capital Management Lp (10% Owner) | Buy | 200,000 | 14.00 | 2,800,000 |
| 2015-06-19 | Hawkes Bay Master Investors (cayman) L.p. (10% Owner) | Buy | 11,700 | 14.67 | 171,592 |
| 2015-06-18 | Hawkes Bay Master Investors (cayman) L.p. (10% Owner) | Buy | 6,200 | 14.75 | 91,450 |
| 2015-06-17 | Jennison Global Healthcare Master Fund, Ltd. (10% Owner) | Buy | 26,149 | 14.00 | 366,086 |
| 2015-06-17 | Hawkes Bay Master Investors (cayman) L.p. (10% Owner) | Buy | 14,200 | 14.38 | 204,125 |
Insider trading activities including stock purchases, stock sales, and option exercises of NVLS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Alpine Immune Sciences, Inc. (symbol NVLS, CIK number 1626199) see the Securities and Exchange Commission (SEC) website.